Novel P45017α inhibitors: 17-(2′-oxazolyl)- and 17-(2′-thiazolyl)-androstene derivatives

Add time:07/19/2019    Source:sciencedirect.com

Twelve 17-(2′-oxazolyl)- and 17-(2′-thiazolyl)-androsta-5,16-diene derivatives were designed and synthesized from 3β-acetoxy-pregna-5,16-dien-20-one (1b) as inhibitors of 17α-hydroxylase-C17,20-lyase (P45017α). Potent inhibitors of this enzyme could be of value as treatment of prostate cancer. Two substituents (methyl and phenyl) were introduced either at their 4′- or 5′-position in order to investigate their structure–activity relationship. Due to the 16,17-double bond, 17-thiazoles were generally obtained in low yield. The pharmacological results showed that the compounds containing 17-(2′-oxazolyl) (14c) and 17-(2′-thiazolyl) (8c) (41.5%) demonstrated reasonable inhibition against P45017α. Their 3-acetate (13c and 7c) were less potent than their 3-OH counterparts. The introduction of a phenyl or methyl group generally decreased inhibitory activity. Surprisingly, 17-(5′-methyl-2′-thiazolyl) (12a) was the most potent compound in this series and was almost as potent as L-39, which has good antitumor activity.

We also recommend Trading Suppliers and Manufacturers of BETA-(2-THIAZOLYL)-DL-ALANINE (cas 1596-65-2). Pls Click Website Link as below: cas 1596-65-2 suppliers

Prev:Cu(II)–dipeptide complexes of 2-(4′-thiazolyl)benzimidazole: Synthesis, DNA oxidative damage, antioxidant and in vitro antitumor activity
Next:POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1)